Project RETAIN: Providing Integrated Care for People With HIV Who Use Cocaine - Scorecard - MDSpire

Project RETAIN: Providing Integrated Care for People With HIV Who Use Cocaine

  • By

  • Lisa R Metsch

  • Daniel J Feaster

  • Lauren K Gooden

  • Yue Pan

  • Carrigan L Parish

  • Drenna Waldrop

  • Allan Rodriguez

  • Jonathan A Colasanti

  • Pedro C Castellón

  • Wendy S Armstrong

  • Michael Miller

  • Christin Root

  • Margaret R Pereyra

  • Carlos del Rio

  • March 3, 2025

  • 0 min

Share

Clinical Scorecard: Project RETAIN: Enhancing Integrated Care for Cocaine-Using Individuals Living with HIV

At a Glance

CategoryDetail
ConditionHIV infection complicated by cocaine use disorder
Key MechanismsIntegrated substance use treatment (CBT and motivational enhancement therapy) combined with patient navigation to improve engagement in HIV care and viral suppression
Target PopulationPeople with HIV (PWH) who use cocaine and are not virologically suppressed
Care SettingOutpatient HIV care settings in Miami, FL and Atlanta, GA

Key Highlights

  • Integrated intervention increased participation in substance use treatment but did not improve viral suppression compared to treatment as usual.
  • Both intervention and control groups showed decreases in stimulant use; oxycodone use decreased more in the intervention group.
  • Psychological distress declined more in the intervention group at 6 months.

Guideline-Based Recommendations

Diagnosis

  • Identify PWH who use cocaine and assess virologic suppression status (<200 copies/mL).
  • Screen for co-occurring mental health disorders and psychological distress.

Management

  • Implement integrated behavioral treatments including cognitive-behavioral therapy (CBT) and motivational enhancement therapy (MET) alongside patient navigation to support engagement in care.
  • Provide evidence-based behavioral interventions such as contingency management where feasible.
  • Address complex medical and psychosocial needs including housing, food security, and mental health.

Monitoring & Follow-up

  • Regularly monitor viral load to assess suppression status at 6 and 12 months.
  • Track substance use patterns and psychological distress over time.
  • Evaluate retention in HIV care and adherence to antiretroviral therapy.

Risks

  • High risk of poor virologic suppression among PWH who use cocaine despite interventions.
  • Structural and social determinants such as stigma, poverty, and unstable housing may impede treatment success.
  • Limited availability of effective medication-assisted treatments for cocaine use disorder.

Patient & Prescribing Data

Cocaine-using PWH who are not virologically suppressed

Integrated behavioral interventions increased substance use treatment participation but did not significantly improve viral suppression; psychological distress was reduced post-intervention.

Clinical Best Practices

  • Use patient-centered motivational approaches combined with CBT to enhance engagement and coping skills.
  • Incorporate patient navigation to improve linkage and retention in HIV care.
  • Address co-occurring mental health disorders and trauma to optimize HIV treatment outcomes.
  • Recognize and mitigate structural barriers such as stigma and social marginalization.
  • Consider contingency management as an adjunct behavioral intervention where resources allow.

References

Original Source(s)

Related Content